MMTV proviral insertion sites and associated genes

Átírás

1 Supplementary Table 1 (Theodorou et al.) : MMTV proviral insertion sites and associated genes Tumor Nr Gene ENSMUSG Sequence J17Rik ENSMUSG GGCCGCTCTCCAATCTGAAGGAGTNAGGACAGGTG CTCGGCCAGNGAGAACCTGTACTTGGACGCTTTGT CCCTGGATGATGATC P08Rik (CF55; gene of unknown function) ENSMUSG GNTCAACGTCTGGTCNTTCAGGGTGTTANCGCTTG TCTCGGNCTGTTGTATTGCTTCCTCACTGNGGATTN TGTGTAGCCTGCGGTTCTNAGGNACAAAGTACTCT CTGCAGGCCACCTCTCCTCTGCACGGGGGAAGGA CAACAGNATGTCTGGAGCTCACATCTATTCCGGTCT CTCCTAGAAACGGNTTACTCTA 171 PT M19Rik ENSMUSG CCTTAGAGGCTTCNTCGAGCAGTGAGGCNGTCAGC TTTACTAACCTTACTACTGNCCTCATGGTTTCTGGC TGCTTTGAACTCTCCTTGAGCACCTTGNGAAGCTGA GTTTCTGATTTCAGCTGCTGGATC 137 PT F03Rik ENSMUSG GGTTCATGTCTGCGTTGCGCTTCAGANNANTACTG CTGTCATTGTNGAAGATCATAGCATTACNTTGCGGA NATCGNTTAGCGTATNTCNTGTGTCCTTATCCTNGC ATATCNGTNNNANNCNGNCNCNNNCNAACACNNAN NGCNTGNGNCCACGGTTCCCCTCCTAAGCAGACGC AGTACTCNAGAGACGACCCACCCATTGGTCAGGAT C 150 PT F03Rik (Q8CC88) peptidase ENSMUSG GTTCATGTTGGAGAAACGCTTAGANAATTATCTGTC TTTTGTTGTCTAAGAAGAATAGGCGCATGGGAGGG GTGTCCTTTCCTTTCCTTGAATTTTCCCCACTGGGC TCCCTAAAACAGAATGGCTGTGCACACAGTCCACA CAAAGAGCACAGCACTCCAGAGACGACCCACCCAT TGGTCAGGATC C23Rik ENSMUSG TGNACCAAGGAGTTCTCACGTGAAGCTTNTCTGCG CCTCCGTGGATGGCGCTCTAAACTTGCNTCTTTGN NAGNACCAGCGANTGCGCACATATGTACACTCACA AAGATCCCATCGATGTCAACACCAGTCTTATTNAGC CACGGTCTCTCCTAGNAACGGTTACTCNA P03Rik (NM_134077:cutaneous T-cell lymphoma tumor antigen se70-2 ENSMUSG GTCCAGCATCAAGGATC K15Rik (NM_029294:similar to phosphoribosyl pyrophosphate synthetase 1-like 1) ENSMUSG CCAGGGCATGGTGATGTCTGNNNTTCATGCTGNTG CTGAAGACCATGTCNGGNTCCATAATCTTGCCNTG GCTTGGTCAATGTTGACATATGTAGCCCACACTGC CACCGAATGCAGGGCAGGTGTACATGTTTTATGCC AGAAGCCATGCTGATATCTATGATC 130 PT G19Rik ENSMUSG GCTTAAAGCACAGGCTGCATANNCGGATGCTGGAA TCCAGCGCCCTCAGCTTCGTTAATCAAAGTAATTGA GATGAATGCATACTTCAGAGATGGTTGATAATAATA GTTCTGAAATCAAGCACAAGAGCCCGGAAGACTAC ATTTCAAAATGTAAACACTCCGATGCACCCAAACAT TCACAGCGGGGAGTTTGAAGTCANCTATGTATGAA CAAACAG M20Rik (ADULT MALE TESTIS CDNA PRODUCT) ENSMUSG GGGGACTTTAATTACTTCAACTACCTGACCCTCAGC TGCCACATCTGTCCACAGAAACGAATATGCCTCATT CCCAGGAGGCCTGTGAGGAGTGGAAGGATGGCAT CTGAGGAGGCTTCAGCACAGGAGCCATCAGTTGTA GCAGGGGCTCTGTGGGATCACATGGGCATTGCTAC CTGA

2 L16Rik (NM_175390) ENSMUSG TCCCATCCACGTTGATC H10Rik (MALE SPECIFIC LETHAL 3 1 MSL3 1 MALE SPECIFIC LETHAL 3 HOMOLOG 1) ENSMUSG AAGCACATGGCTAGCACTGATCNGCTGCCATTTCG TCCAGTGCTACTGCCAGAATGCCACACTTGTTGAG ATC 191 PT L11Rik (Q7TMU3) ENSMUSG CTTTGGACTGTCAGTGTGGCCNGANCATAGTAAAC AAAAAGTTTAGTGTGTTTCCTAAAGATCCAGATACA GGCAGGAACCAGAGCAGGTAGGAACTTTGTGGGC CATGATAAGGAATGCAGAAAAGGGGATTTTAGCTA TCCCTGAAGTAGTTACTGTGTCTAACATGTGTGGTA TTGTGATC E06Rik (CJ11_MOUSE):novel with Immunoglobulin/major histocompatibility complex domain ENSMUSG AGCACGTATAAGTATCTGATC E06Rik (CJ11_MOUSE):novel with Immunoglobulin/major histocompatibility complex domain ENSMUSG GCCGACATTCTTTTCTACAAGTAGGAGGAAGAGAG AGCTTGTTGAGAATAAATATGGACGTTGGAAATCTC CAAGCCTAGTGACATTTCTTCCAAGAAGGCCACAC CACCTGATC I17Rik ENSMUSG AGGTACNTTGTGTGAATGTTTCTCT F15Rik Ubiquitin conjug enzyme ENSMUSG TGANGANGNGCTNAAATGGTGTNCCTGGCCNGANN ANGGNCTCAAACTTGCTTTCTGAAGACCAGGATGG CCGTTGAACTCACA I03Rik (Q9D0H0) ENSMUSG GCAACCTAGGTCTTGGATTG F08Rik: zink finger prot F02Rik (NM_172437) TruD domain containing gene (t RNA modifier) D03Rik (NM_ ) ENSMUSG GAGCAGGACGTGANGAGGCTCTCTTTTACTGCTAA TAAGGACGCCAGATCCCATCGATGNCGACNCCAGA CTCNTTCNCCACCAGACGGATGAGCCCATNANAAC AAAG ENSMUSG ATCCTTCNCGGTGCCTACAAGAGAGNCCNCCACAT TCAGCTACACAGNAACCNTTGCAGATAAGAAGAAT CAAGANCGNGTNCAAGATC ENSMUSG GTCTGCCCAAACTGGTCTTCAGTTGAAGAACTCTGT TAGTTGACCTAAATCTGTTTCTAAAAGGCCAAAGTT CATTCTGATC L20Rik ENSMUSG GGCACCCAGTTGAGATTCTTTTGCTCTTTACTTGAG CCTGGGTGTGTGATC 182 PT E01Rik (Q9D5E5)MUS MUSCULUS ADULT MALE TESTIS CDNA PRODUCT 173 PT E13Rik pathched related family 9 ENSMUSG TGATAATGGACTAAACCTGTGANNCCTAAGTCAGCT ACGATTAAATATTTTCCTTATATAAGAGTGGCCATG GNCATTGNATATCTGTACAGCAATCGGACACTAAG ACAAGCAGACAGACCANGTTTAAGCACTGGCAAAT ACATTATTTTTCCTGACCGTAATAGATTACGTTTACT GCAAATCAACTGTTGCATAATGATC ENSMUSG GTGCCCATGCACACTTTGTGTGNGGGGAANNNGTN CCANCCACTGGGCCGCCCANGTCAGAAAGGTTNAC TTTATGCATCCCACCTGNAGTAGTATTCTGCGCTAA GCTACAGGGTGATAGCNGAGGAATGCGCCATAGG CGGAGCGTGAGGTAGATGCTCTGTGCCAAGGACT GATC 166 PT I11Rik ENSMUSG TGTGGGGTGGCACAGACACACCAGAAGAGTGCAC CTGGATC F22 Rik ENSMUSG CACTGCTGATGCATCTAGGGCCAGTCAGACGGCTC TGCAGATAAAGGCACTCAATGCTAATCCTGGTGAC CAGAGTTCAATCCCAGGAACCCACACTGTGGAAGG AAAGATCAAAATTCAGGTGACAGCAGATGCTGGCG AGGATGTGGANAAAGAGGAACACT

3 D02Rik (TAS1_MOUSE: Threonine aspartase 1, Taspase 1) G11Rik (Rho related GTP binding; NM_026294; Ras GTPase superfamily) ENSMUSG CCTCGGATGTTCGCATCCCGTATNCTCTTGCCCNC TGNGTNNNCTCCAGGTCAATNGGTTCANTNNNAAT TATTATCTGACGCACTTGTANCANCTCANNNNTGAG ATAATGNATCGTGNNTACTCTGTGTCTTATNCTGNT CCCATCGATGTCAGACACCTAGTCTCATTCAGCCA CGGTCTCTCCTAGCAACGGTTACTCTA ENSMUSG ATCATATGTTCAGCCCCCNTCGTNNTGAGTGGCAG AACCTACCCTCCCTTTTCAAATTCNTATAACCTAGG AAATAGTATCCTCTCTAAAGAAAATNCAAAGAGTAG AGCAGAGTACTGATAGTCCACACCATTCAGAGACT GCCCCACCTGGTGATCCCATCGATGTCGACACCAG TCTCATTCAGCCACGGACTCTCCTAGCAACGGTTA CTCT L15Rik ENSMUSG GACTCAGAATACATGGAACATGAACCTGGNGTTTG TTNAAGCTAACGTNGGAACTCAGGCCTGTCTGATC L06Rik ENSMUSG TCCAGTGTTATTTTGACTATGGCAGGNCCTGATC D11Rik ENSMUSG GGCCTCAGAGGGTGTGAGGGAAAAAGTGTCTGGTT ATAGGGAAATTCTTAATACTGCCTCTTGTTACAACA CCCTGGAGGGAGGTAGCTGGCCCACCCTCTTCTGT CATTTAGTACCTGGGACTCCACATTTGACATACTGT TAGCATGGCCNGATC E21Rik ENSMUSG GGTGGGTCTGCNNATTTATCCTCGGGGTCTANATC TGTGTCCTAACAGGGTTACAGGAGTCTCTTACCCTC CTCCTGCTGCCTTTTTGGTAATGCATAGCTGTTCCA CCACNNTCCCCAAACCAGGAGCCAGATGAACACTT CCCACACAGATACACCATCCTATCAAAGCCTGGTC CCCAGAGTGAAGTGGAAGGAGAAGGCAGTCATCAA ACTCCTTTTCATCTGACATCTTGGGACCGAGTATTA GATGGTCAACCAGGAAAGCTGTGGACAGTTGGAAA AGTACCAGGGCTGCAGGAGAGCCTGGGGCTGTCT CTCCTAGCAACGGTTACTCTA C23Rik (SUBMANDIBULAR GLAND SECRETORY GLX RICH PRECURSOR GRP ENSMUSG CAAAAATGCTCATTTGGAAACATATGTGCATATTCT TATTATCTTATTGTTATATCTGTATGGATATTTCACA TGGAACAAGTACTTTTGCAGAGTGATGACAAAATTA TGGAAACAATTTAAATTTCCTTATTAGTATTCTGAAA ATTTTTATATTATCAGACATAACTKGATC B05Rik ENSMUSG CTTTATCCCAGATGAAAGGCG F24Rik (NM_ with Molluscan rhodopsin C- terminal tail) E02Rik (Q9CYD8/Q8C4V9 ) F09Rik prot with unknown function ENSMUSG GGGTCCTGAATGTGGTAAAGCCCNCTTAACCATGT ATTTCAGATACTAGAGATC ENSMUSG AATCTTGGGTGNGTATATTTGTNTGAAGGCGNAGC TATGAATTCCATCTTGNAGTCAAAAAATGTATGTCA TCAGTAGGAATTCAAACCTAGCCAATAGCTGAAGG ACTGATGGTGCTCGTTCCTTANCAGCCATTTTCCAT CGATGTCGGACACCGGATCTCANNCAGCCNCGGG CCCTCCANNAAACGGTCACTCAA ENSMUSG TAGCTTCAAGCAATTGCCAATAGAGTCTGTGACTCT ACCCCAGTAAGAAGAAACTTGACCATTACCAACCTA CCTCTGCTCAAAACAACTCGGGGAGGGGTAGAAG GAAATGTTTATATTGCTTTGATCCAAATGGGTAAAC TTTGTCAGAATTTTGTATCATGAGTAGAACCCTCAC CCTATGGGGTGTAGGAGTACATCATCTGAATAAAAT TGTATGCAGTAAAATTCAGGACTCTTA 9 60S ACIDIC RIBOSOMAL P1 ENSMUSG CACATTGGTTGTTTGTCCAATCTTATGCGTGGTGGC CAGCAGTAGTCAGTGCCACTCAGCAACGGCACATG TGGCTTCCCACAAATATATCTGGGTAGACGGCTTG TGATC

4 E02Rik (NM_177872, ADAMTS PRECURSOR A DISINTEGRIN AND METALLOPROTEINASE WITH THROMBOSPONDIN MOTIFS ADAM TS) ENSMUSG TAGTCTATTTGTTTTAGGAAAGAGCAGTAAATGTAN CATTTCAAAGGNTTTATAGCACCATGGATGTTGGG GAACAGTGTGTTGATC D04Rik (Q8BJ19:unknown with Histamine H3 receptor domain) ENSMUSG AGGCCCTCTGCACACATGTTACAATTGTGTAGCTTG ACCTTCTTGTGGGACTCCTAACAGTGGGAGAAGGG GCTGTCTTTGATTCCTTTCTTGGCTTTTGGGACCCT TTTCCCTCATGCTGGATGATC 144 PT B15Rik ENSMUSG CATTGCATGNACGTATTCCGAGATGTCNGGGTTTA CAGGATTAGCACTGTCATCTGTTCTCTNATTCCCTA AGCCNCGTTTTCAGTGTTTCTGTCTGATCTCGCTTC TCTCACTAATGTCACAGACACTGTCTCCCNGTTCCC ACCCTTTCTAATTCATGATAGGATTGAGTATTTCTA GTATATCTAGCATTGATCAGGATTTGGCCCAGAGTA GCACTCTGGTCATCCTTAGGAAGGTGGAACCCAAG CATTAGGCACCTCTACTAGAAGTTTAGGATGGGAC TTAANGTTCTGANCTTTAATAGCAGCATCCCAGAGA TC C07Rik (NM_177802) LARGE NEUTRAL AMINO ACIDS TRANSPORTER SMALL SUBUNIT L TYPE AMINO ACID TRANSPORTER O19Rik (= NM_027828) ENSMUSG GCTCTGATTAATAAATCCCTTGGAAGTTCTGAATAT GCTGTGCAGCCAGCGTGTCTGATC ENSMUSG GTTAGCACCTATAAAACTGTTAATCCATGGNAGTTA GTTTTAAGGAATCCAAATTCCTTTCTAAAATAGAAC AACTGAGTTCCATATAGATGGAATCTGTGCAGGAG AGCAATGGACACTGCTAGGTCATTGATC A04Rik ENSMUSG TCCAGTGTTATTTTGACTATGGCAGGNCCTGATC F23Rik (unknown gene ) D24Rik (family of DYNAMIN BINDING SCAFFOLD TUBA with a Rho gef) ENSMUSG GGGTCAGAGGTTCAGCCCATTATCATCAAGGTAGG AGCATGGCAGTGTTCAGGCAGACATGGGGATATAG GAGCTAAGAGCTCCACCTGTTGATC ENSMUSG AATTANCTTTGTTTTTGTCCTTCATAACCCAGGAAA CACCTAACTTTATAGAAGCTTTACTTTCTTAAAT H19Rik ENSMUSG GGGTTCACGCCTTCATGGTTGCTTGCCAGCAGTGC CTTAGCTATGGTGTTTCCGCTGATCAGTTATGTCAT GGCTGGCAGCATGAAAGTCTCCAACAAAGGCAGAA TGCAAGAGGCGGGCCAGCTGGGCAGTCTCTGACC CCAGCAGCTGTAGNGGAACGCTAGATTGCTTGGTT GGGACTTCTTGTAGCTAGGAAGCTTCTGCAGGGCA AGTGTGTTAAGCTCTTCCCTGACCTCTTTACTTCTG GNGTTTTGCTGTATAAGCTTTCAAACAGAGCAATGG ACTCCCGTCCACATAAACTCAGGTGTGAGCAGTTG ATTAGTGATGACAGACCTGAGATCCCATCGATGCG ACACCAGC A04Rik ENSMUSG GGAGCTNTGGAGCCGACTTATGTCTCTCCTAGCAA CGGTTACTCTACGGNCNCTNCTAGCAACGGTTACT CTACGG 182 PT A930004K21Rik ENSMUSG AATTCATACCCTCAATTCTGCCATGCACATTATAAAT TTCATTATTGTCTTCCTGTTGATTTANAATTCACTGA TTATTTT

5 49 Abca4 (ATP-BINDING CASSETTE, SUB-FAMILY A, MEMBER 4; ATP-BINDING CASSETTE 10; RIM PROTEIN; RETINOBLASTOMA BINDING PROTEIN 2-RELATED) ENSMUSG CCTCTGGGATAAAAAGGCCAAGCAGCTCCGCCCTC AAAATGCTCAGATGAATTAACAGATTAAACAGCGAA GAAAAAAAATAATGCCGTCCGCAGCGTGGTGATGA GAGACAGACCGAGCGGTGGTGACAGCAGCCTGGC ACCACGACGA 64 Acacb:acetyl-Coenzyme A carboxylase beta 187 PT Acsl4:Long-chain-fatty-acid-- CoA ligase 4 (EC ) (Long-chain acyl-coa synthetase 4) (LACS 4) 109 Act16a 53 KDA BRG1- ASSOCIATED FACTOR A (ACTIN-RELATED PROTEIN BAF53A) ENSMUSG CTATGAGGTAACGGACCTTCTCTTCATACTGGGAAT ATGATTTAGGAGTAAGGTTTGTATCTCTGATTTTGC AGCGGGATTGGCTTCCTTCCTCGGATCCTCCCTCT ENSMUSG TCCTCCAANTTTGANTNTNTANTGACAAGAGTCACT GACATGTGTTTGTTTCCAGGATAANCAGGATC ENSMUSG CCTCACATCACCCTGGCACCATTGCATGTGTTCTTG TGTGTTTCCCACAGCTGGGTATACTGCAGG 76 Actn1:actinin, alpha 1 ENSMUSG CGTGCATTTGCCAACTCTANCTAGGAAAAGCTCAG AGCTGGAGAGATGGCCCAATGAGACCACTCGTTCC 171 PT Adamts10 ENSMUSG GAGCTCTGTCTGGTTGTTNGTNTGTAGCCCATGCC TATCCTGAGAACTCATAGAGATCTACTCGACTGCG CCCACACACAAAGGTCTCAGAGCAACACTTTGGCA AGAGGGGGCAAANANTTATATAAAAGCCAGAACTT CAGGGAGTTTGATC 2 PT Adamts12:ADAMTS PRECURSOR A DISINTEGRIN AND METALLOPROTEINASE WITH THROMBOSPONDIN MOTIFS 49 Adamts18:a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif 92 Adcy2:ATP PYROPHOSPHATE LYASE ADENYLYL CYCLASE 92 AI (chemokine (C-C motif)-like), member A2 27 AI (expressed seq) or C330021A05Rik Rab related gene) 11 AIP; AH receptor-interacting protein//nm_ ENSMUSG GGGCTATGCTAAAGAGTGNAAGGATTANGCCNTGA GTAGGTGGATAGTTACNATTTTAAGAAACTGGNCAA GCTGTTCCTATCTATGTTGAAATTTTNGTATCCCTC CAAATTGNAAGTTGAAATCCTAAATCGGTATGTTGC CAGGAGGTGTAGGCCTTTGCNNAGCTCAACCTTCN CAAAGGGAATGANGAGACCTTANAACCTGGCTCCT TATGGCAAGGAAANANGGACTGACATCGTCAAGNA AGCTGGTNAGCNANG ENSMUSG CACTGCTGATGCATCTAGGGCCAGTCAGACGGCTC TGCAGATAAAGGCACTCAATGCTAATCCTGGTGAC CAGAGTTCAATCCCAGGAACCCACACTGTGGAAGG AAAGATCAAAATTCAGGTGACAGCAGATGCTGGCG AGGATGTGGANAAAGAGGAACACT ENSMUSG AAATTGGACTGACTCTTGACCCATTGGCTTCTGCAT AGGTAGGTGCTGTCTCTATGCCCCAACCATCGATG TCG ENSMUSG GTCCATCCTGAGTCATTTCTTCCTGCCGTTAGAACC AACGTAGACTGAAAACAGAAAGCTATCTACAACATC CTTGGGTC ENSMUSG GTATACCAGAATCTATCGCCTANNGGATCCGGGGG TCTCTCCTAGC ENSMUSG GCNTGCNGGCNCTCAGNCAGCAGNNACACACACA TGCGCGNACGCGCGCACACACACATACACACATAC NCACACACACNCACACNGACNCTGTTTNTAAAGAG TAGGCCTGGATAGTATGATATCTCCCCGGCAGGTG AAANGCCCTGGGCTCAGTCCTCAGCCCNAGGACAN ACANAACACTGGGAAGATGGAAACTGAAGACTTAA CCTTAGGAAAGATGTAAGGATGATGGACTCCCATT GCCCCTGCTCTCGGCACACAGTAAATTACTAGCAG ACATTCATATGCGGATGGTTTTGGACAAAGGNTTTN GGGTTGCTCCATTTGGAAATGAGAGGTAAGAAAAA GCCAGTTCCCATCATGTGTGGGTACAACTAGACAG AAGACCAGATCCCATCGATGTCGACACCAGTCTCA TTAGGCC

6 153 PT AK ENSMUSG CCTGAGTCCCCCACTGGTCCCAGNNACTCCTGGTA TTGGGGTAGATGTATCTTCCTCACCTATGATC 95 Aldh1a7 ENSMUSG GCCTGTGCATTTACGTGTGGT 14 Alkbh3 ENSMUSG GGCACCCAGTTGAGATTCTTTTGCTCTTTACTTGAG CCTGGGTGTGTGATC 111 Als2cr19 in intron :amyotrophic lateral sclerosis 2 (juvenile) 71 Ap4m1: Clathrin adaptor complex, medium chain 94 PT Aqp4:Aquaporin 4 (WCH4) (Mercurial-insensitive water channel 4 Arf3; ADP-ribosylation factor 3 (or Wnt10b) 109 Arf3; ADP-ribosylation factor 3 (or Wnt10b) 95 Arhgap6 :RHO GTPASE ACTIVATING 6 66 Arid3b:DEAD RINGER 1 B CELL REGULATOR OF IGH TRANSCRIPTION BRIGHT ENSMUSG GTTCAGGGTCTGCTGCTTCTCCACGGGGTNCGTCN GNGGTGCTACCAGGTGGATC ENSMUSG AGGACGGCGANCAGACTGACTGGATTCGATTTCTA CCCAGCTACCCTACCCCGTCTCCCGGGTCAAAGGA TNCAGTCTNTATAGATGANGGATC ENSMUSG CTATCCCCCTGACTGTGGGAGNNCACTCCCCCGAT CATGGAGTCTATCCGCCGCATCATGAGTCTATTCAC CTGATCATGAGT ENSMUSG GCGTCTCCTCCTCGNACNNNNCAAACCCGGCGGC AGGTGNGTGTCCAGGNCTTTCACCCAGCGAGCCCA AGGCCCCTTGACTCCCACNGCCAGGATGATC ENSMUSG GCAGAACTACTAAGGGGAAAAG ENSMUSG GGAGAATAGTCATGCGGGGatc ENSMUSG GCATTATTCAACTGACATGTNCNCCCNCCCNGCAT GTGANNANAACTGATCCTTCATTCTCGGCATCNNTT ATGACAAATTTTTGNTTGCTTGCCAAGTTGCACAGA ACGTGTAAGTAAATTCTGGATGGCACNGTAGATGT CAGAACGACTAGATCACATAGATGGGAGTCGGCAT GAGGGGACTTCTGAGTTCTTGTGAAAAAACTGCAA GAAAACAAAAGTCTTGTGACCTCAATTTCTTAAAAG AAACAAGGAATTATTCTTGGGATGTGTTTTAGTGCT GATC 12 Astn2 ENSMUSG CTCCCGGCATGTTCAATCTTCCACTTCAGGTCTCTA GNAAGcACCAGCTCGAGAGTGTAGGTGCTGGTTGC CGACCGGGGCAACTATCGTATACCAAGTGTTCAAC CGCAAAGGCTTTTTGAAGGTGATCCCATCGATGTC GACACCAGTCTCATTACAGCCACGGTCTCTCCTAG CAACGGTTACTCTAGGTCNN 87 Astn2 ENSMUSG CCCCCCGCGGCNGGGNAAACCTCNGNGCAGAAGN TCNCCTCGACCNAGGAAAACTTACTGGAGAGCTGC AGAGGAGGAAGGCAGCCTTGGAGGGCGTCCCCAG GGATC 44 Asxl1:Putative Polycomb group protein ASXL1 (Additional sex combs-like protein 1) HISTONE ACETYLTRANSFERASE 178 PT Asz1:Germ cell-specific ankyrin, SAM and basic leucine zipper domain containing protein ENSMUSG GGTCCTTGTTCTTTACTACTAGCATGACACTCAGTC TNTATGATCTAGNAAGCAACTTAGGCTGCTCTGTAA CATCTCGGCCACTGGAGTTTGGGAGGACAGAGGG GGCAAAGCCTGACACGGCTGGTCTCCAGTGGGAG CAATAGGGGGTTGAGAGGCATCTTCCAGCCCACTT GTAAGCACACCNTGGGACCCTCTTCAACAGGCAGT TCTCTTCCTTTCTGAGAGAAGCCTGAGTCTTCTCTT CTGGCTCTGGGCATGGTAGCCTTCAGCTGGAGTGT GC ENSMUSG ATACCAGGAAANGAGCTTTACNNNGTTGTCTTTGA GAGCAATGCCAGCCCCAGCATCAAATGTGGAAGAG TGGGAGTTGCTGTTGAAGACACGAGAGACAACCTG GTCCTCAGTGTAGA 191 PT Atf2 ENSMUSG GGCCGCCCTCTCGCCTGTCACGNNGAACGCACGTT CGTGTGGAACCTGGCGCTAACCCATTCGTAGACGA CCTGCTTCTGGGTCGGGGTTTCGTACGTAGCAGAG CAGCTCCCTCGCTGTGATC 130 PT Atf7ip2 (Q8BPC5) activating transcription factor 7 interacting protein 2 ENSMUSG CACNCCAATNANANAACCAGAATGAGCTGAAGNTT ACCTTTTTATAAGTATTATTAATNATACTCTTTTGAT C

7 89 Atp1a1Sodium/potassiumtransporting ATPase alpha-1 chain precursor 8 Atp2a2 Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (EC ) (Calcium pump 2) 131 PT Atp2b1 Q8K314:PLASMA MEMBRANE CALCIUM TRANSPORTING ATPASE EC_ PLASMA MEMBRANE CALCIUM PUMP PLASMA MEMBRANE CALCIUM ATPASE. 174,3 PT Atp2b1: Q8K314 :PLASMA MEMBRANE CALCIUM TRANSPORTING ATPASE EC_ PLASMA MEMBRANE Atp2b1 Atp2b1: CALCIUM PUMP PLASMA MEMBRANE CALCIUM ATPASE 36 Atp2b2:Plasma membrane calcium pump isoform 2 19 Auts2:autism susceptibility candidate 2 74 AW ( NM_134096) member of the TAFA family 84 B230104P22Rik : Q8cGE1 kinase ENSMUSG CATTGTGNNCGCACATCCANTAAGCTCAGGGACCC ATATTCTGAGTGGCCACTGAAGCTGACTTGCCAGT TCTGAGAATGATGACAGGTGAAGTGTAGGCAGCGT CCAGGTGGCACTGAAGCATCCTTGTCAGGGCCTCA TTGCCTGAGTCTCTGTTGCCCACGGTCTCTCCTAG CAACGGTTACTCTA ENSMUSG GGGCTGCCTGTGTACATTTCCATTATTGTATTGATG TTGAACCAGGGCAGTGGCTAAAGTCACTCCACTGA CCCAATTAAACAAATAAGAGCTTGTGGTTGCCCGCT TGATTGATCTGCGCAGGATAAGCAGTAAAGTTTCCT TTTCCTGGTTCGAGAGACTCCTCCTATTGCATAACT TGTGAACTGTGATTTGAGTGATACAGANAAGGAAA ATANAGATGTTCTACAAAATGTTCCTGAGATCCCAT CGAT ENSMUSG TTGCNAAATGAATAAGNAATGNNATATGGTTNCTCT GGCTGGGAATACCAGTCATATGCAATGGNAAAAAG GAATCCCATTGTTTGGAAATAGGCTCTCATGTGATC ENSMUSG CATACTTTACCTATCATCCTTTTNCTTCTTTACTCTG TGCTTTACCAGTACATAGCTTAATTTACACAGAATTT CTACAATTGAAGATTGGGATC ENSMUSG GGCAGGAGAGNCCTCTAAGGTAGGTGGAGAGCTA TAGAAGACACCCATATTGACCTTTGCCCTCTTTAGG TC ENSMUSG GCCTGCTCCACGGGTTGGGGTCTCGGTTGCAGAG AAATCCTTGTTCTCCAGTTCCTCGGCAGCAGGCTG AACCGCTGGGGTTTCTTCCAGTCCCCAGGGCAGAT GCATGATTCCTAATCCCTAATACCATGGGAAAGGG TCTCTCCTAGCAACGGTTACTCTA ENSMUSG CCCCTTTTTTCTTTTTTCCATCNNATGTCGANAGCA GATCTCATTCAGCCACGGTTCTCTCCTAGCAACGG TTACTCTACGCCGCACAAGAGTAGAGTCACCATCG ATGTCTTTGTCTGATGGGCTCATCCGGTCTCTCCTA GCAACGGTTACTCA ENSMUSG GGCCAGGGGTAGGGCACATTTAANTTCACTAAGCA GNAATTACAGTGTGGCAGCCGTACGGTTGTTAGGC TCCCTGCTTTTGTCCCTTGCCAACTTGTTTGCGAAC AGAGAGAGATCCCATCGATGTCGACACCAGTCTCA TTCAGCCACGGTCTCTCCTAGCAACGGTTACTCTA 181 PT B3gnt5 :UDP-GlcNAc:betaGal beta-1,3-nacetylglucosaminyltransferase 5 ENSMUSG GAGCTCCAGTCTTCANGCTCNNNNGTTGTATNGNC AGCCATTATTGTAAAGCACAGATCATATCTTGTGAG GAACTATCACAAACCCACTNTCAAAGCATATTCATC CTACCACCCATGTTCCTCCAGGGCACACTGTAGAG TGTGTTGCTGGGGATGATTCTAGAGAGACTACAAG GCATAATTTTTCAACTGGGCTTGGAATACCTGTCAC TGGATC

8 94 B930037P14Rik (Q80ZJ7) sorting nexin 6 family member ENSMUSG CCTAGCATGTTTCTCAACCAAAGAAATAGATAAAGA AAATGTCATCCATTTACACAATGTAGTGTTACTCAG CTGTTAAAGACAGTGACATCATGAAATTTGCAGACA AATGGATGGAACTAGAAAAAAATTGTCTTGAGTGAG GTGACTCAGACCCAGAAAGACAAACATGGTATGTC CTCACCTATAAGTGGACATTAGCTGTTAGTAAAGGG TGATCATGCTACAATCCATAGACCAAGAGAGACTAA AGTAACAAGGAAGGTTCAGGGTGGGGGGACTCAT GATC 112 Bace2: beta-site APP-cleaving enzyme 2 ENSMUSG CTGTGATCATGATGGTGTATTGTTTGACNAACTACG TCCCTCCAGANCATTAGTGTGNGATC 78 Barx2 ENSMUSG TTACCCCCAGCAGAAAAACTTCGTTCTTGAAGGTAA TTAACACATCGACCCATAACTTAACTGCATGCAGTA GAGCGAGAGACTTACGTGACTTTATCAGATGCTTC CTCTCAAGACTCAAGGATC 125 PT BC (NM_024480:SH3 DOMAIN BINDING 5) 62 BC (NM_198609:RIBOSOME BIOGENESIS RLP24) (but further downstream: synovial sarcoma translocation gene) ENSMUSG GATTCAGTTTCATCCTANAAGGTTGTCNNCACATGG TTAGAACCGTGTCGACATAGTCTTCATGGAGAGCT GGGTTCCCATACTACCTGGATCTCTTTGTTTCTCCC AGCTTGAAATTCCTGGGATGATC ENSMUSG GCTAGACATGGAAACATTTCTGTGTGAT 20 BC (NM_145570) ENSMUSG CCCCTCCTGGNTTCTCAGTCTCCGNCACTAGCGAN NGAACCCCAAGNACCACCTCCCTTCTTTGGATCTCT CCTAGCCAACGGTTACTCTANNN 115 BC030440; NM_ ENSMUSG AATTATAGGTTTCATGGATC 107 Beta-parvin:Calponin-like actin- ENSMUSG GGAGGAACAGGTACAGACTA binding in 1 32 Bin1: Myc box dependent ENSMUSG CTTGTTGGTACTGATGATC interacting protein 1 (Bridging integrator 1) 45 Birc1c (glycine receptor, beta ENSMUSG GCCGTTCTGTTGATGNNATACNNAATAAGCGATATC subunit ) AAACAAGATTGATC 41 Birc4:baculoviral IAP repeatcontaining ENSMUSG GGCTGCTCTTCCAGAGGACCTGAGTTCAGGTCCCA 4 GCACCCACATGGCGAGCTCATAGCTGTCTGTAACT CCAGATTCCAGTGGATC 131 PT Bmp4:Bone morphogenetic ENSMUSG GCTGTGCATACTCTCTGATC protein 4 precursor (BMP-4) 182 PT Bre:BRAIN AND REPRODUCTIVE ORGAN EXPRESSED 91 C030018G13Rik (MUS MUSCULUS 10 DAYS NEONATE CORTEX CDNA PRODUCT:WEAKLY) 26 C1d:nuclear DNA-binding protein; C1D protein; small unique nuclear co-repressor 162 PT C8b:complement component 8, beta subunit in intron withlow density lipoproteinreceptor,thrombospondin,eg F-like domain domains ENSMUSG TTGGTATGCAATTGANANAACATNCNNTACATTTGC TTAATTGTATTTCTGTGTTTTTGTTNGNTTGNCTTGN TTTTTTAAAGATAAAGTCCTGTTANATGTCACAGNAT GGCCCATNCACTGTCTTCCTGCNTNANCCATCTGA ATGCTGGAAGTTTAGGCNTGTGCCACAATGCCTGT CCCTGAGTTTCTGTTGTTCAAAATGTATGATC ENSMUSG CAGATACTACATCTTGGTGTCNGACTTAGCAAACAT TGGGTAACTGTGGTAGCAGTGATGTGCTATGACTT GGTACTGAAATCTAGTCATGTGGTCTA ENSMUSG CAGAATCNNAGATTCAGATTATGAACGTATACGTTC TGGCATATGTGTGTTCATACATACATACATATGCAT GAATATATCATATGTATGTGAATTTATTG ENSMUSG TCNGCGCTTNNATCTTAACTNNNCGTATCATTGATT GGACTTAAGGTAGATGCNCTGATTCAGAAATGCAA ATGTNNGGGTCTGTGTTTGCAAGGCCTTACANTGG NAAATGATGNANTTCNCACT

9 128 PT Cabc1:Chaperone-activity of bc1 complex-like, mitochondrial precursor (Chaperone-ABC1-like) 113 CacN1e (calcium channel, voltage-dependent, R type, alpha 1E subunit ) 17 Cacna2d1:Dihydropyridinesensitive L-type, calcium channel alpha-2/delta subunits precursor 57 Camk1:Calcium/calmodulindependent protein kinase type I 95 Cancab4 CALCIUM CHANNEL, VOLTAGE- DEPENDENT, BETA 4 SUBUNIT ENSMUSG CTCTCTCTCCTCTGTGTTCCCCANNCCTCCCCATGG GTGGGAGGATGTTCAGGCTGCAGGACCACTTTAAA AAAAAGTCAGGGGAGAGCCAGGCTGTGGTAGCATA TGCCTTTTAATCCCAGCATTTAGGAAGCAGAGGCA GGATGATC ENSMUSG ACACCTCTTCATGGATTGAGANGCGTCGNNNGCGG TGTCCNNNAANCTTTGGANAGAGCGACGACTATTC TCGTAGATGGCCGCAAGCTTCCTCTCCTCCGCTCA TGTGAACCATGNAAGTCCCGAGGACCACCAACCCC TTGACACACATACACGTTTGATCCCATCGATGTCGA CACCAGTCTCATTCAGCCACGGTCTCTCCTANCAA CGGTTACTCTA ENSMUSG CCAGGCAAATTCACCACATTCTACTG ENSMUSG GGACCCTNATGNTGCAGGATGTGACACCACAGATG AAGCTCTGACCACATGTCAGTCTGAATACTGNGTAA ATTNTTCCCTCCCATCGTCCTGTAGGCCAGNCAAA GTCTTGNYYACANCTAGTACGAGNATATGTCTGTTC CATANGCAATATATGATGTCAAGGGATAGGCACCA AAAGCTGAATTTCCTCGTGTACCACTTTCGTCGGCC CAGTGMGCCCATACACAYAATGAGTAAGTGCACAC AGCCAGCGATCAGCGA ENSMUSG CGGGGAGGACCCTTCCTTCCTTCAGCTATGGNTAG CTTG 64 Catnb b-catenin ENSMUSG GGACATTAGTGGGATGAGCAGCGNCAACTGCGTG GATGTGATC 97 Ccbe1 (collagen and calcium binding EGF domains 1) 235 PT Ccne1, G1/S-SPECIFIC CYCLIN E1 44 Ccne2, G1/S-SPECIFIC CYCLIN E2 50 Cd226:CD226 antigen precursor (Platelet and T cell activation antigen 1) 140 PT Cdh1:Epithelial-cadherin precursor (E-cadherin) (Uvomorulin) (Cadherin-1) (ARC-1) ENSMUSG GCCTAAGGCTTTCACTATGTGGGACNTCTTTGGAA CTGAAAATTTGCTGCAGNTAGACTAGGCTCAGGCT GGCCTTGAATCCCATCGATGTCGACACCAGTCTCA TTCAGCCACGGTCTCTCCTAGCAACGGTTACTCTAN GGNNTCTCCTAGNANCGGTTACTCTA ENSMUSG TCAAGATGCCCATAGATGCTGTGTCCAGAGAGGTA CACTTTCTGGTCCATGGATC ENSMUSG ATCCCAATGCAGATACCAGGGCTCCTCCCTGACAC TTCAGTCAGGGTTAATTTCTTTCCTGTTCCCCACGA GCAGGAGGCATGACTACTGGTTTTATTAAAATCCCC ATTAAAGGCAAT ENSMUSG TAGAGGATGCTTGGAGGCCTTGTGTGATC ENSMUSG GTGTGTGTGTGTTGTGTTTGCTTATGTGAGAGCAG GCACCTGTTGAGGCCAGAAGAGGATGTCTGATC 90 Cdh11 ENSMUSG TTCATGAAATGCCCNTATGAGTCTAAAACGACATTA TCTTTATAGCACAGNAAGCT::::GACACAAGCATCTA GTTATATGATCACTGGNTGTCCAATCCCTAAGCTTC ACAGTGATGTGTACCTATGCATGTGAT 11 Cdh2:Neural-cadherin precursor (N-cadherin) (Cadherin-2) ENSMUSG GGAAAATAAAAGTTATATGAGGNAAGTTGGAGAAG GGGATTTGGAGGGAGAGGGGAATGGGAGGCTNNA TGATC 74 Cdh6 ENSMUSG AGCTGTAGTACTCCTTCNGTTCTNCCTTGGGTAGG NGAAAAGCATNGANGTCNCGAGTAGNGGNTAAGG AGGGAGCNNCCTANGAGGGCATAAGTANACAGGG GCAGGGAGGANGGAAAGATAGAGTGGAACCTGAT C 11 Cdk6 CYCLIN-DEPENDENT KINASE 6 ENSMUSG GCTCTGATTAATAAATCCCTTGGAAGTTCTGAATAT GCTGTGCAGCCAGCGTGTCTGATC

10 44 Centg2:centaurin, gamma 2 ENSMUSG CNATNTTTCCTTTGGGACAAAGGCTTGAAAGTGGG TTTGCAATAGTNAAGGTGTTAGGNGTGTTGGAAGT CTNGCCCNCTAGGGGTGCAAGGNCNTTACT 89 Centg2:centaurin, gamma 2 ENSMUSG CGTGAAGGCGGAGCGNCGTGTTCTCAGCGGGGCT GAAATATTCCACGCGTTTTTGATC 6 Chmp2b (CHROMATIN MODIFYING 2B CHMP2B) 189 PT Ckap1 cytoskeletonassociated protein 1 16 Cmkor1:(Chemokine orphan receptor 1)G PROTEIN- COUPLED RECEPTOR RDC1 HOMOLOG ENSMUSG TCCCCCTTGTTTCTTTTTTAAACCAAGCACGCTGGA GATCTTATTTGCATTTTGCNNTNTCTTTGATTGTNG GGCCCTTGTTCACTATGGAATCTTCTGCACCTGANA TTCTCTCTTCCATCTCATTGTATTTTGTTGCTGATGC TCGTATCTATGGGTCCAGATTTCTTTCCCACGGTCT CTACTAGCAACGGTT ENSMUSG GTGGGTAGCTGACACCCTGTCTGGCAAGTTAAGAC ATGAACGTTAGGCAAGGCAAGTCCCCTACCACAGT TGAATAACACCCCAACCAATGGGAGCAGGGTAAGT ATACAACAAAGACGTGTCCCTAAGGAAGCCCCTAT TCCTAATCCCGATTAACTTGTTTGTGGATTTTAGAC TTAAAAGCCTTGTATGATC ENSMUSG CCTCTGCCAAGCAGGGATGGAAAGACAGGTGATC 140 PT Cnga3:Cyclic-nucleotide-gated cation channel alpha 3 (CNG channel alpha 3) (CNG-3) (CNG3) (Cyclic nucleotide gated channel alpha 3) (Cone photoreceptor cgmp-gated channel alpha subunit). ENSMUSG GACCCNGGCAAGAGGAAGCAGNNCTCNTAAGAAG CTGAGNCATCNCTCCAGCCCCCCCCCCATTAGGGC GAANTGAACATGTAACCCCTTAAAGGC 31 Cntn6; contactin 6 ENSMUSG TTACCATCATATGGTATGATACAAGAAGGCACAGAT GTCCTGAAAGCACTTAGGTGCACTCTGAATTGCTG TATACAAAAGATAACAGAGGAGCTGAGCTAAACCTT AAGGCATGTGTAGTGGCTGCTTTAACAGCTATTGG AGAGTTTCCCCTGCGGATGAGCCCATCAGACAAAG CA 72 Cntnap2:contactin associated ENSMUSG AAATGTCTACATTGGTCCAAAATCAGAAGGGATC protein-like 2 83 Cntnap2:contactin associated protein-like 2 ENSMUSG CTATCCTGGAAATTACCATAATGCACCATGATC 100 COP COATED VESICLE MEMBRANE P24 PRECURSOR (predicted gene) ENSMUSG GGGGATTNTGAAAGCCCTTGCGTCCAAAGNATAGN GTTCTTTTTGGGCAATGTCTTACATCTATTTTCACCC GAGCCCTNGAATTAGAAAATTGATTCCTCTTTTGCA GCCCTATTACCATGTCAGGGATTTCTACTGTCCATT TGACGATGTGCAGCCGCAATAACAAAACCCGGTGA TTACTGGANC ENSMUSG CCCATCTCTGGAATTTCTGATC 51 Cops7a: Proteasome component region PCI 163 PT Coro2b ENSMUSG CTGGGGATCCTTGAAGGTGCNNTAGGGTGAGAATT ATAATATTGGGGTGGGGTGCTCTCTTGTGGTAATTA TGAAATATTTTTGATTGTGTGCATGGTGTCTGTGTG TTTAGGTTGGAGGTCAGAGTTCAACCTCTGGACTT CCTTAGAGGCCATCCATCTTATTTTTAGACACAGGC TCTCTCACTGTACATNGGACTTACCAGCTGATC 78 Coro6;coronin G-protein beta WD-40 repeat 190 PT Cox7c HIGH MOBILITY GROUP HMG 22 Cox7c:Cytochrome c oxidase polypeptide VIIc ENSMUSG GAGGCCCCCTTGTCGGTAAGCTCTGAGATC ENSMUSG GATGTACCTCAGTGTGACACAACAGTTTAGGTGGN AGAGATGGAATACCTGAGTGGCACATGCGAGGTAG AGAGAAGAAATAGTGGTGACCTGTCTTTGCTGATC ENSMUSG CCAGTCTCATTCAGCCATGATC

11 21 Cpne5: Copine V ENSMUSG ATCTTTGTCCAATCATTTAGANTTGATGATTTTAAAA CACATCCCTGCTGGGCGTGGTGNCACATGCCTTTA ATCTCAGCACTTGGGAGACAGTGGCAGGTGGATTT CTGAGTTCGAGGCCAGCCTGATC 11 Crisp2; cofactor required for Sp1 transcriptional activation subunit 2 ENSMUSG CTTAAGAGGAGGAGTGTGGTGATGGGAGCTCCCA GGGTGACAGTGGATGAGACTCACAGCCCACCAGG GTGCAAGCCCTGCAGGCAGGTCCAGTGATAGGAA AGCTGGATGCTGAAGACTAACGGATGAGCCCATCA GACAAGNNACTTNTNGANGTTCCANCCAAGCAT 91 Cry1:CRYPTOCHROME ENSMUSG GAGTTGCTCNTTGGATNGCANGTCTGACGTNGCGT CGTGTNCGTTGTCTCTCTTTGCTAGACACACTGCG GGAGGGTGNTCTTTCTGATC 111 Crygf: crystallin, gamma F ENSMUSG CACGGNTCTCTCCTAGCAACGGTTTACTCTAAGGG ATCTTTGTCTGATGGGCTCATCCGTTTGTGTCTTTG TCTGATGCGGCTCATCCGNTTTGTGTCTTTGCCNG AAGCGGCATCANCCNATTGTGTCTCTCCTAGCAAC GGTTACTC 89 Csnk2a1: Casein kinase II, alpha chain (CK II) ENSMUSG CTTTAATAGTAGAGTATACATAGCATCTGNAACAGG ANNTTTCTGCTGGAAGCANGNAATTTTCACGGGGC GTACTGCTCCCCTTNGTTTAGTGCAAGAGTAAGGC AGCCAACCTCCCAGTGTCCTGCTTGTCCAGTCTAG ACAGCGTGCTGTCGGCAGTCAAGGTAAAGGGCCT GTGGCCACGGTCTCTCCTAGCAACGGTTACTCTA 48 Ctsb:CATHEPSIN B CYSTEINE PROTEINASE PRECURSOR ENSMUSG CGGTANGCAGAGGCAGATTTATCTCTGCAGTTTGT GNNCCCCATCATGCCCCGGCCATCCTGATC 134 D0H4S114 ENSMUSG AATCACCAGGCGTCGTCAACCGCACAGACCATATA TGTCCGCTAGGATC 97 PT D12Ertd771e ENSMUSG AGTNCGTCGGCAGCCGGAAGCAGAAGAGTATGAA CAGTTGGTGCCCACTTCACTTTCTCCACTTTCCTGT TCATTCAGCTCGAGTCCACCGGATGGGATGGNTCC GACTACTCAAGGTGAATCTTCTCTCCTCAGTTAGAN CTGCCTGGTCCNCACAGACGCACCCGGANGTGTG TTTCCATGNCGACACCGAATCAGATC 116 D130059P03Rik ENSMUSG CCTTCCGGNGTTTTACGGGCTNTCCCACCCTGCAA AGAAAGNAGCATACGTTAGACTTATTCAGTACCTGT ACTGTTTCCATAAATATATAACAAAAAGACCTGTTA GAAAAATTCACACAATTTTTACAGAGAAACCCTCTG TAGACAACTGGATCCCATCGATGTCGACACCAGTC TCATTCAGCCACGGTCTCTCCTAGCAACGGTTACTC TAA 116 PT D3Bwg0562e:plasticity related gene 1:LIPID PHOSPHATE PHOSPHOHYDROLASE EC_ PHOSPHATIDIC ACID PHOSPHATASE PHOSPHATIDATE PHOSPHOHYDROLASE TYPE PAP PAP2 ENSMUSG CCCCTTTCTTTGCAGCATGTTGTNNCACACTTCTGT CTCTTTGTGTGATAATCTCTTCCCCTTGAATGTGAT TTATACCTTGTACCTTACCACACCATTTCTAGAAAC ACTTCCTGATGTTCCATTGGCAATTCCCTATTCCTT AGAACTACATTCTGTCACTAGGCATGTTGTAACCAT TTACACTAATGCTTGTATACTATGAGTCTCTGAGGG ATGATC 68 D530031C13Rik (NM_177269) 61 D730001G18Rik (HYPOTHETICAL PROKARYOTIC MEMBRANE LIPOPROTEIN LIPID ATTACHMENT SITE CONTAINING PROTEIN) 28 D8Ertd594e:similar to BH3- only member B protein kinase ENSMUSG GATTCATTTTGGCTCATGATC ENSMUSG CACTTGGGAGACGAGACTCCAGCCATATCCATGAA GGATTATCCTGATTGTATTATTTGAGGTGAGAAGAC CCACCATGGTTGTGATC ENSMUSG CAATAGCAACTGAAGAGATANGCTGAAACCTGCCT TTACTTCTGAAAGGAGAGTCGGGAGAAACTGATC

12 76 Dach1:Dachshund homolog 1 (Dach1) 31 Dbi:Acyl-CoA-binding protein (ACBP) 46 Ddx3,DEAD-BOX PROTEIN 3 (DEAD-BOX RNA HELICASE DEAD3) (MDEAD3) 14 Defb7 (defensin related beta 7) 171 PT Dhx40 (ATP DEPENDENT RNA HELICASE) 10 Dicer1:Endoribonuclease Dicer Double-strand-specific ribonuclease mdcr-1 78 Dlg5 SIMILAR TO DISCS, LARGE HOMOLOG 5 (DROSOPHILA 132 Dlgap2: SAP90/PSD-95 associated protein 2; PSD- 95/SAP90-binding protein 2; SAP90/PSD-95-associated protein 2 60 Dmrt3:Doublesex- and mab-3- related transcription factor Dmrta1(doublesex and mab-3 related transcription factor like family A1; doublesex and mab- 3 related transcription factor 4.) 136 Dnahc5: dynein, axonemal, heavy chain 5; dynein, axon, heavy chain 5; axonemal dynein heavy chain 5 31 Dnahc5:DYNEIN HEAVY CHAIN, CYTOSOLIC DYHC CYTOPLASMIC DYNEIN HEAVY 81 Dnaja1: DnaJ homolog subfamily A member 1 (Heat shock 40 kda protein 4) (DnaJ protein homolog 2) (HSJ-2). 191,2 PT Dnm2:Dynamin 2 INTERFERON INDUCED GTP BINDING MX 76 Dok5:Docking protein 5 (Downstream of tyrosine kinase 5) ENSMUSG TCATTATATTTTACTTAGGTGTAAAAAGAACATCAGA CTGCCTGTTTCTGTGATC ENSMUSG TTCATTTTCATGACCATCTCTACTGTGCTTCCCCAC ACCTGATC ENSMUSG CTTTGAGGACTTGGCGTGGTGCTGTGTTTTGAGGA GATGGCCTTGGGCCCA ENSMUSG CTTACACAGCAGAGGGAAGTAGAAAACCGGCCTGA CCAGGGGCACAAATCCCTTCTGGTCAGTGCCAGCA CCCAGTCACCTAGGGCGTGGAGTCTGTGGACAGC CCCACAGTCCCCAGAGGACTCTCCACGTGATC ENSMUSG TTCCCGCTGTTCCNGATGACTGTTAGNTAGGAGCG CGCTGGGNTGTTCCTGTGTATGTCTGTCNCTAGTTA CCATC ENSMUSG GATGCCGTNTCTTGCTCTGACGGAGTTGTGATC ENSMUSG ATTAGTGAATNCANGTCACGGTTGAANGAACTCCC CCNCATTNCTTGAAGACNGCGTGCTNAAGTGCGGT NTATGNTGCAGGACACAGTAGAATCGNAACCTCAT ANTAATCAAGGGCCCTGGAAATACCACCAAATGAT GCAAAGATACAAAAGTAATTTGAAAGGACAGTTCTC ATGGCTA ENSMUSG GNNNCGGCGCGGCCACACACAATCTCACAGCGTC TCCCCGGTCCAAGNATCCCATCGATGGTCGACACC AGTCTCATTCAGCCACGGTCTCTCCTAGGCAACGG TTACTCAAAA ENSMUSG CGTGTGTATCATGACAGAGGACCTGCAGGTAGATG ATCC ENSMUSG GTAGTAGGGAAAGCTGNTAGCNTGCTAGTTNNCCT GGTTGTCAACTTGCACTATATCTGCAATGCAACTAC AATCCAGGNATTGGGAAGGCTCACCAGTGATCCTA ATCTGGAGACTGGGAGATAGAAATTTCTGATATGG ATCCCATCGATGTCGACACCAGTCTCATTCAGCCA CGGTCTCTCCNAGCAACGGTTACTCNAA ENSMUSG CTTCCCTAACCTTTCACAATCTNTNCAGATAGGTTN TNTCCTCACTCCCTTCTTGTCCTCATCTTTCTGCTTA CCACTATCAGGTTGATCTTTACAAAATGCAATGAGA TC ENSMUSG GGCCTTTCTGGGGTAATGTGAATGACCATTTTAACT TTGTTTAGAGTGATGATC ENSMUSG AACCAGCANGGCGCTCAGGCGCACTACACCCCNN AAACATGAGAACATGGCCCACNGAATCAACTGATG GGGACTCATGGGAATTTGAGAGGTCAGGAAATCTA TAGGAGCTCTGACCTAGCGTC ENSMUSG ATAGGTCACTAGTGCCATCAAGGGNCACAAATATAT CTAGACTTAATGATC ENSMUSG CTTTTGGCTTCCCTTCTTTCTCNNTCTCTCCTCNNC CTCCAATCCTCTCTTTCCCTTCTCTCTCCTCTTCTGA TCCCACCCCTCTTACGGAACACATTTATTTAATCAA AATGTTGATTTACAAAAAAATGATC

13 28 Dpyd: DIHYDROPYRIMIDINE DEHYDROGENASE [NADP+] 182,2 PT Dusp6:Dual specificity protein phosphatase 6 (Mitogenactivated protein kinase phosphatase 3) (MAP kinase phosphatase 3) (MKP-3) ENSMUSG GGAAAACAATAACTATNGAANAACTAGAANCATATA TTTGGNAGACTCAGCTATGATGNGAATAATCACAGT ACAAACTCTGG ENSMUSG CCTTAGTTTCCATGNACNCCGCCGTGGNAAAAATT GAATGCAGGNATGGNTTTGACTTTCACTGGATACC CATCACATGCCCTAGCGTCTTAACAAGCAGTCTTTG CTTATGTTATTTCATTCACGCTTGTAGGACTCCCCG TGGATGTCATCTGAAATCCAGGGAGGTTTTTNAAAG TGCCCGGNATCACANANCTAGNGAATTGGTGAGTT TAAACTGGATCCCACNCCTACCGGATTTCAAAACAT GATC 28 E030011O05Rik ENSMUSG ACCAAAGGTNACTGAAGAAACAAGCANATAAGACC AAGANCCCAAACTTNANATNACTTGCATTGAATGAN GAACAAAAGAAATAAAACAAACATAATNCATGANGA TANCAAAAGATTGAAAAGNCAACCAAGGAGGCACA AACAACG 11 E2F7 in intron but may enhance expression of small isoform 74 Edar: Tumor necrosis factor receptor superfamily member EDAR precursor (Anhidrotic ectodysplasin receptor 1) (Ectodysplasin-A receptor) 10 Edg5 ( lysophospholipid receptor B2) 161 PT Ednra:Endothelin-1 receptor precursor (ET-A) 187 PT Egfr:RECEPTOR TYROSINE KINASE ERBB PRECURSOR ENSMUSG TANAAACATGGCTCCAGGCANGTGGAGCCANGGCA GTCAAAGCTCGNCNAANTNNNNCTCTGTTTNAAGG AGTCGCTGANTCNNTGACACCATCGANGAC ENSMUSG TTCCCTTTCNGTCTNTTNTGATTCTCCANGCACNCC TCAAAGATCCTTAACTCGTATCGCCATNTTCCNCAN ACGGTTGGGCCATNCACTTCCNGGTATCTTTTTCCT CCGGCGTCTGATC ENSMUSG CCCTGGAAGTAGTACAGACAGAATGCTGACACCCT TTGTATCAAGTGGCAAATGTCTAGCCCTAAGCTCCA GCCTGCGGTCACCCTAGACCCTTAATGATC ENSMUSG CTGNTTGCTTGTCCTTTCGGNTTCCCTANGAGNTAG CGNCGACTATCACTCCACTCTAGAGTNNNCAAGGA ATCCAATGGCATCTTCTATGGTGTGATC ENSMUSG GTATCTCTAGCCCTTTGCAGATGATAAGTATGGTTT TGATTTCATTGCTAAAATCTAGCTTGTTTGGAGATA GGGTTTGAGATTATGATC 15 Egr3 ENSMUSG GCNNCTTCGGTTGTGGTCAGCNTTCATCTAGGGGG AAATCGCATGTATCTCGCTCANNTCCGCATGGAAA AGGAGAAGCCAAACACGTAAGCTTCACAAAGACTG GAAACCTGGCTTGGGATTTTCACCTCAGTAGGTAG AATACCCGAACGGCCCGAAGTCCTGGCCTCCATCC GCAGCACTACAAAGTAAACAGTAGCAATGTCTGTC CNCAGTCATGCTGCAGCCAAGTGGCTGAGTTGAGA TTTAGGGTCTCTCCTAGCAACGGTTACTC 10 Egr3 ENSMUSG GGCATCTTCGGNGNGTCAGCANTACNATAGATGAC CTCACATGAACTCCTCAACAGCCNTGAAAAGACAG GCNAACACTAAGCTTCACAAAGACAAGAACCTGGC ATGGGTCTACAGCTCAGAGGTAGAATACCCGAACA GAACAAGTCCTGGACGTCCATCCACAGCACTACAA AGTAAACAGTAACAATGTCCTGTCCACAGTCATGCT GCAGCCAAGTGGCTGAGTTGAGATTTGGGTCTTGG ATGGAGGTCACAACTCCAAAGCNGGCTAAGAGTCA GAGGGGAGAGCAAATAGCTGCTGGCTTGTCACGT GACCTCCTCAGTTTGGAATTGTGATC 173 PT Eif4g2:Eukaryotic translation initiation factor 4 gamma 2 (eif-4-gamma 2) (eif-4g 2) (eif4g 2) (p97) (Novel APOBEC-1 target 1) ENSMUSG GTGGGGTACCAGAAATTTGTGGTGCAGCTGATCCT TACAGTATTTTATAGTGATC

14 44 Elk3, ETS-DOMAIN PROTEIN ELK-3 92 En2:Homeobox protein engrailed-2 (Mo-En-2) 76 Epb4.1l1 BAND 4.1-LIKE PROTEIN 1 (NEURONAL PROTEIN 114 Epm2a (laforin:tyrosine specific protein phosphatase and dual specificity protein phosphatase) ENSMUSG CGTTCCAGNAGCAAAAACCTAGTGGCACTGAGGTA AAAGTAAGCCANTAGGCCACTCAATTCTTCATGACC NTTTTATCTAAAACCACACATGAAGAAGCAACAGTA AGTGACNTAGTACAGTTAGTGGGACAGGTTTAAAAT AACTTTGNTATTCTTGGAAGATGCTGNTTTGTTTGG TTGGCCTTTTTGTTTTCTTTCAAGACAGGGNTTCTC TGTGTAACCCTGGNTTGCCCTGGCACTTGTCCTATA NACCAGGTTAGNCTATCT ENSMUSG TCCCNNTTGTTCTTACCCTTGCTCCCTTGCTNNCCC TCTTTCCACCTTCCCTCCCCTCCTCTCTCCATATGG CCATGACCAGCCTCTGCTTCCTCACTCTCTCCCTGT ENSMUSG GACCCTGACCTTCCCATGCCTCAGCTTCTCTGTTTA GGCGGCTAGGAAGCTCAGTGATC ENSMUSG bp than GGCACTGTCTTCATCCTTTGCCGTGCCACCGNAAC CTTGTC 32 Eras: ES cell-expressed Ras; small GTPase E-Ras 88 Eras: ES cell-expressed Ras; small GTPase E-Ras ENSMUSG CAGTTTCTGGTAAGGAAGGCCGGGACCTCTGACTT CCTCGGAAAGTAGTGGTGAGTTCCGCAGGCTCGAG TGAGGGTTACAAGCCATACGGAATTAGAAAATTGC CTTGTCCGGGTTCTGAACCACAGCGATGGCAAATA CATCCTGACCGCATTCCGCAATCCTTGCAGGTACY TTGCTAGGGCTGATC ENSMUSG TCTTTCACCTCTTCCTTGAGCTGCTGGGGGAATGG CTTTGCCTACAAAGTCTAGCATCTTGCGTACCTGAG ACTCCGGCACCCACATGCACCAGATC ENSMUSG TCTGTAGCAGCTGTTTGTCTGAGCGCCCTGTACTA GGGGGCCGGTGGGCTGGGTGACAATGATC 89 Eras: ES cell-expressed Ras; small GTPase E-Ras 181 PT Erbb4 ENSMUSG GAGAAGAANGNGTCNNTTCACGGCNNCTTTCTTAG AAGAACTCTTTCATCTANCAATACAGAAATATCACC ATTACCACTCCTAAGTTATGATGATTTTAGGCACAT AACAACAAAAACCTTCTGTCAGTTGGTAATATATTC ATTAAGATAANTCATTAAGGGAACTGCTATGTATTT AGTTCTTCTAGGACTGCATCTAACCTTGCCCTGNAA AATATTGACNAATAAGCAAGTAGCCNACAAAA 67 Esrrb; Steroid hormone receptor ERR2 (Estrogenrelated receptor, beta) (ERRbeta) ENSMUSG CATAGCCTCTGCTTCAGTTCCTGCCTCCAGGTTCCT GCCTCCACTCTCCTTGAAGATGGCCCAAAGTGAAA TAAATCCCTTCCTCTCTAAGTTGCTTTTGATCCCATC GATGTCGACACCAGTCTCATTCAGCCACGGTCTCT CCTAGCAACGGTTACTCTAA ENSMUSG GATACAGTTATTTGCACCCAACCNNGGACAGACGC NNNATGATC 43 est NM_145591:similar to zinc finger protein Ets2, C-ETS-2 PROTEIN ENSMUSG CTTTTTCAAATGTTTGNTCTCTCCTCATCTATAGAAC TGATATCAACCCTAGCTCACTAGGCTGGACTCTCAC ATGTTAGGAAAAGCTTGCTTCTTGTACAGCACGNTG CCTGCCATCTCCTGCTTTGCAATGCTCACTTACAAG AGTCTGTTGTATC 7 F830005K03Rik ENSMUSG TCTNCATTTCGTAGCATCTAATGANGCCNAGANNNN NGGAAGACGATGTGCTGACTGATTCAGTGCTTCTT ATAAGGGGGANCAGAANATCACAGGTAGAAATATG GTAGACNAATTGTGNAGCCGAGACTGNNCACAGAC TACCNTCCTNACACTGNCTCNCNTGGTAGATC 5 F930048N03Rik (XP_ , Zn-finger, FYVE type gene) ENSMUSG CCCTAATGGNAACGCCACNTNCGNCCTATCCTGGG NNNAAGCCAGGNACACTGGAATTCGCTCTCGTAGG AAATGGCATTCGCTTGAAGTGTGCACACCAGGGGA GTCACGTCCCTTCTCTGCAGTCTTGGGGGGC

15 74 Fabp4 (Fatty acid-binding protein) ENSMUSG CGNNTACGTGNGGCCATCTTCCTNCATNNATNAGG CTCCNTCCTCCCAGAAGACAGGCTCCACCCTTCAT GCNGACAGGAAANACACCTCAATGNAGTCAGGCTC CACCCTCCCATACAGTTNNGCNCCANCCACANANG GTTTNCCCTAGAAAGCAATCCCNGCCTCCTCTCTG GCTATCANAGACTGGATCCCATCGATGNNTAACAN CGGNTCTCATTCAGCCACGGCCNTCTCCTCAGGAA CGGTTTACTCNA 10 Fat3 protocadherin ENSMUSG GAAAGTCACTACTTCTGAAAAGTCGCAAGACTTGNT GAGNTATATGTGGCANACACACAGACTCTTTAACAT TYGNCAATATACGAGGAGACTCATGATC 44 Fau; Ubiquitin-like protein FUBI ENSMUSG CCCCACTCAGAGCNACAAATGTCTCTAGACTATTTG NGTGTGTGTGTGTTATTCATGATC 12 Fbxw4 ENSMUSG TGGGGCCACCACATCTCGCCCANTTCCGCCTCCGG NAAATCTCACTGGCCTGGGGTNCACATGATGAGGT ATAGNTGTGCTGAACTGGATGCATCCTCATCGGAT GTCGACACCAGTCTCTTTCNCCCGACGGTCTCTCC TAGCAACGGTTACTCTANN 16 Fbxw4 ENSMUSG GGTGCCACCACTTTCTCGCCCATCTCGCCTCCTCA GCTCTCACTGGCCTGGGGCTCACTGATGAGGTTAG TGTGCTGAACTGGTGATC 29 Fbxw4 ENSMUSG GGTGCCACCACATCTCGCCCATCCCGCCTCCTCAG CTCTCACTGGCCTGGGGCTCACTGTATGAGGTTAG TGTGCTGAACTGGGGATC 45 Fbxw4 ENSMUSG ACCGGTATCTGGTATTGCCCTAGAAATTACTTTTTG ATCTTAACAAAACAACAACAAAAACCCCGCCTACCT TGGCCCTTTAGTGTTCTGGGTCTGTAGAGGAGATC AATGCATGCTTTACCTTTGGAAGGGTAAATGACATG AT 51 Fbxw4 ENSMUSG GATTTTGNCTTCTCNAGNACATGGGTTTGGTTAGCN TTGNATGGCACTGTCTTTCTGATC 58 Fbxw4 ENSMUSG TTTAGTATACGTATTCGNATATACGTTTATACCTGG GCTTTATACAAATTTATCAGGCAAAAAGCAATCACA AGTAGAAACAACTTAAGAAGCCCACTTACCTATAGT GCTAGTCCCAGTAGTAACAGTCTATCTCTGTCCTTG ACAATGTTTGCTTCTCTTCAAGAGACTAGTCACATT TACCACTAGCACCCTACCAGGCTGGAAAAGTAAAC CAGGCTGGCCTTGAACTCAGAGATC 62 Fbxw4 ENSMUSG CCGCCTCNNTCGCACACGGTCTGCTCCNAGAANGA GGNCTCTNTGTGCTGAACTGGGGATC 80 Fbxw4 ENSMUSG AGAATCCATATAAAATTCCGTCTTCTATCAGNATCA ACAGAGCTCAGCAAGATGGATATTAATGCGATAGC TTTGGGCTCTCTCCTAGCAACGGGTTACTCTA 111 Fbxw4 ENSMUSG ACAGGNAACACTGAGTCTGCANCGTTCTAGCAGGA ACCTCAGGGTTCAGTCATCCCAGCATCTCGTCACT GAGCCAACTGAACAACCATCTGTAACTCTAGTTACG GGGGGTCCCACGGATACTCTCTCTAGCAACGGTTA CTCTA 108 PT Fbxw4 ENSMUSG AGAAATGTGNAAATGTAAATGGNATNCCTAAAGCAA GCCGAAGAACATCTTNAAGTGNAATCTGCCTGAAA CGGCCCGAGGGACCACNTCTCTGCAAAANGACAC CTCAATATGACCCTTCCNGAACATNGTCTGCTCCTG AGCCGGNCATAGACCCAATGGNCGCTTGTTGTAC 130 PT Fbxw4 ENSMUSG CTGTAAGGAGCAACAGAAAGCCNAACTTTGCTTTG GTTGGCTTGAATCCCAGGCATTTTAGCCAACTTCAA TTATAGTTCAATATTCCTTCAATGAGTTACTCTGTCC AAGCACATGATC 17 Fbxw4 ENSMUSG GCGATGTATCTGCTGCTACTCTGCATCTATTTTTAT TTACAACCACAGGGCAGACGGCAGAGACCGGAAC CTGATC 53 Fbxw4 ENSMUSG CGTTTAGATATCTGAACCAAATGACTGAAATCTTTTT TGTGACACTTCCCCCAGCAATTGATC

16 35 Fem1c:SEX DETERMINING ENSMUSG ACCAGCATGTCCTTTCACTTGTTGTATTGATC FEM 1 63 Fgf10 ENSMUSG CCAGTAGCCACCACCTCCAGCTGTCTCTTTGCCTC GCACCAGGTCTTACCCTTCCAGTATGTTCCTTCTGA TGAGACAATTTCCAGTGCCGAGAGTTTCAGTACAAT GTGGAAATGGATACTGACACATTGTGCCTCAGCCT TTCCCCACCTGCCGGGCTGCTGTTGCTGCTTCTTG TTGCTCTTTTTGGTGTCTTCGTTCCCTGGGTCTCTC CTA 137 PT Fgf10 ENSMUSG CCTTTCTAGGTCCTGAGACAATTCNNAGATTCCCAT CCCTAATGTCAATAAAATAAAATAAACCAAAGGTTC ACCCATGTATATATGTATGCATACTCTTTATGAGTTA AATTTTCATATCTTCTTTGTTAGATC 150 PT Fgf10 ENSMUSG GAGGNGAAGGCNNNNNANAGCGNNNAAGNCAGGC GCCCCCCAAANNCAGAAGTGGCGNGTTCGGANAG ACTTCACGATCGAACAGGCACCACCANACNGAG 44 Fgf10 ENSMUSG GAGNATTTCCAGTGCCGAGAGTTTCAGNACAATGT AGGAAATGGATACTGACACATTGTGCCTCAGCCTTT CCCCACCTGCCGGGCTGCTGTTGCTGCTTCTTGTT GCTCTTTTTGGTGTCTTCGTTCCCTGTCACCTGCCA AGCTC 79 Fgf15 ENSMUSG AGGTNCTGGTAGATCAGAATTTCCTGGGCACGCCC ACCTCACACCCTGCAATTCGTTCCCACATTGCTGTA ATTATAAAAAGCCACTTAATAGACTCTCGCTCTCCG TGTGAAAAGCACAGGCTCTTCTATACACAGAGAGA TC 51 Fgf17 ENSMUSG CCGGGCCAGGTGGGGCTGCGAAGTCGGAGCTGGT CCGATTGGCGTACTCGCTCTCTTGGGCTACTGGCT TCGGGWCAGAGGTCCCCGGGCGCAAAGGATTGGA GCTGCGAGAGCGTCCTCTATCAGGAGGCTGGCCC CTATGATC 5 Fgf3 ENSMUSG GGGAACAGAGGTACTTGTGGAAACCGCCCCACCTT GGGGANCAGGGAATTATGTGAGCTGATAGAGAGAA TTCAAATGCCTAAAGATCAAGGACAGTCACTGTGAC ACCCCTACTCCATNTCCAGCCCTACCNGGGAATCT GGGGGCCCTGACCTCTGCCTTCTGGGGGGGGCCC CTGTGATCCCATCGATGTCNACNCCAGTCTCATTCA GCCACGGTCTCTCCTAGCAACGGTT 8 Fgf3 ENSMUSG AGCGNCNAAAGGCTTTGGNAACCNNNCCACCTTGN GNAAAGGGAATTATGTGAGCTNTNCGAGAGAATTC AAATGCCTAAAGTATCAAGGACAGTCACTGTGACA CCCCTACTCCATGTCGAGCCCTACCAGGGCATCTG TGGGCCCTGACCTCTGCCTTCTTGGTGGTGTCCCT GTGTTCCAGGTCCTCCCCGCACCCCCAGCTCCTCA CCCAGCACAGCCAGTGGAGCATCTTTTCCTGCTCA CAGTATTGACTAAGACAAAACAAACCACAGGACAG CCTGAAATGGCTGCCCAGACACGGGCTTTCCTTGT CCAATCCGGCAACTTGCAGACGGTCTCTCCT 11 Fgf3 ENSMUSG AGAGGGACAGTNTCAGGCCTGTTGATC 14 Fgf3 ENSMUSG TCTAGTAGGCTTCGTAAGCCTTGCGAACCAGAATTA AGGCTGAGCTTTTTGGGGGTGATC 15 Fgf3 ENSMUSG GTGAACAAGGTACTTTGGAACCCCTCCACCTTGAT CAACAGGGATTATGTGAGCTNTCTAGAGAGAATTC ANATGCCTAAAGATCAAGGACAGTCACTGTGACAC CCCTACTCCATGTCNCAGCCCTACCAGGGCATCTG TGAGGCCCTGACCTCTGCCTTCTTGGTGGTGTCCC TGTGATCCCATCGATGTCGACACCAGTCTCATTCAG CCACGGTCTCTCCTAGCAACGGTTACTCTA

17 17 Fgf3 ENSMUSG ATATGAACCTGTGGAAAAGCCATAGGCATTCTCTTG ATTAACGGCTGGTGTGGGAGGGCCGGGCCCTGCA CACTGTGGGAGCTGGCAATCCCCAAAGCAGACTGT AGCAAGCCATGAGGAGCAAGCCAGTGAGCAGTGC TCCTCTGTGCCTCTGCATCAGCTCCTTTCTCTAGCT TCCTGCTTTGAGTTCCTGCCCTGACCTCCCTAAGTG TGACTTGTGACCTGGGAGTTATCTCTGATC 18 Fgf3 ENSMUSG GNTGAACNGAGNCACGTTNGGGAACGCTCNCGNC CTGNGAGGANATNGCGTGTNATTCATCGCNGNAGT CTGTTGNNGCAGNAGGANTATGAGAANGCCTGGAG AGATCCATNGCACGAGCTCCACATGGGGGCACAAT CGCCATGCATCTCACTGATANACGNTCCTACCAGG GGATAGNGGTGNTCNTCCTGGACCTCGTGCCTCTC TAGGTGGTGTCCCTGTGATCCCATCGATGTCGACA CCAGTCTCATTCAGCCACGGTCTCTCCTAGCAACG GTTACTC 22 Fgf3 ENSMUSG AGGCATSTGCCCTTTGTCCTCAGTNGGCTAGGACT GACTTAAGCATCCTTCATTTGAGTCCCTGGGCCTTT GCCTCTGGTACTGCATGGGTGCTACTCTAAAGCCC AGGCTCCAGTTCAGTGGAGCCTTTCCTGCTTGTTG TGGGGACCAGCCAGACACCCTCCACAGGTGCAGT GGTGCAACATGGGAGATGAGGAAGGACCACACCA GGGTGCAGGTGGACTTTTTCAGCCAGCCTAGGACC ATGAATGGCAATGGTGTGTCTTCATACACAGTACAG GTAGGTTCTAAGTCCCATCCACACCCACATGAGGT AGAGTGAACTCTCCCCAAGTTCAACGGCTACATCC TGTGGGCTCTTGATC 33 Fgf3 ENSMUSG GATGACACAGCCGCAGTCATGTCTGTCACTGTAGT GGGGACATTGAGGCACCAGAGACAGGCCACAGCC AAGGCTAGCTGTATGATC 35 Fgf3 ENSMUSG GATGACACAGCCGCAGTCATGTCTGTCACTGTAGT GGGGACATTGAGGCACCAGAGACAGGCCACAGCC AAGGCTAGCTGTATGATC 40 Fgf3 ENSMUSG GGTTTCTCTCTGGATAATGAGGTTNNGCNCCAGGG AAANGGTGCAGGNGTTCNTCCCCGGCCCTGNGGA GGGAAAGAGCGCTGTAGGATTCTGGAGGACAGNG CTGGTCCTATGGCCCCTTCAGTTGCCACCTGACTC CCAATGCCTCAGTTCAGCCTTAAGCACTGGATCAAT GGCCAAGGTTTGCCGACTTGGGATCCCATCGATGT CGACACCNGTCTCATTCAGCCACGGTCTCTCCTAG CAACGGTTACTCTAA 41 Fgf3 ENSMUSG AACTTTGTTGGANTTCCAGGNCCTNNGGCTAGNAA GCAGGGCTGGCAGCTGCCATTGCTGNACCCCCAG CAAAGGCCACAGATACCTCTGCAGGCACCGCAGTT GCCTCCAGCCTAAGGACCTCTTGAGCTCANCCCAT TGCCACANAATCCAGGGNTCAAAGGATTTGAGATN TGACAGTAGAACTATGNNGGCCAATTAGCTACCTT GNGCATGGAGCATCCATGTCCNGGGTGGCCCCNN GTTCCCTCTGG 44 Fgf3 ENSMUSG ATCGATGGNATCCANNAGNNGGGGTACAATGCAGA GCGCTGTAGCGTANGTACCAAGCACTCCCNAGAGN GTCCATACANCTTAGACNNAGACGCNGCCNCNGCA CGAGNCNTTCGGCACCAAGNCANGANNCAGTNTAG CGCNCANNCCNGTGCGAGCCCATCANAGANNGGC CGCACACAAAAGTCCTCTCTCTTCCTGCCNCGAGT CTNNTCCACAAGGACCATGAGATGGTGCGGCTGTT GCAGAGTAGCCNGCCACNAGCCCCANGAGAGGGC AGCCAGNCCAGGCATGCCNGTTNAGAAGAAGC

18 50 Fgf3 ENSMUSG AGGCATSTGCCCTTTGTCCTCAGTNGGCTAGGACT GACTTAAGCATCCTTCATTTGAGTCCCTGGGCCTTT GCCTCTGGTACTGCATGGGTGCTACTCTAAAGCCC AGGCTCCAGTTCAGTGGAGCCTTTCCTGCTTGTTG TGGGGACCAGCCAGACACCCTCCACAGGTGCAGT GGTGCAACATGGGAGATGAGGAAGGACCACACCA GGGTGCAGGTGGACTTTTTCAGCCAGCCTAGGACC ATGAATGGCAATGGTGTGTCTTCATACACAGTACAG GTAGGTTCTAAGTCCCATCCACACCCACATGAGGT AGAGTGAACTCTCCCCAAGTTCAACGGCTACATCC TGTGGGCTCTTGATC 52 Fgf3 ENSMUSG TTNCCNNNNAAGGGGGNATTGCANCAANNGCANCA NCNGTNTGANTCATCCNCNTTTCGCTTGTCTAGGG NTTGGCTGTCCTTTCCTGGGGCTNGNGGCTGGCTA CTNTGCAGCAAGNCCGCACCATCTNATGGNCCTTN NGGCCCANCACTNGGNGCAGGAAGANAGAGNNCT TTTGNTNCGTTGGNTCTTNAAGNCCCTGNNNNGCG ACCCTTGCCATTNANCGACACNTCCAAGGNNTTTG GNACCA 65 Fgf3 ENSMUSG GACAAGGTACTTTGGGAACCNGGCACCTTGTCGCC AGGGATTATGTGAGCTGATAGCAGAGAATTCANAT GCCTAAAGATCAAGGACAGTCACTGTGACACCCCT ACTCCATGTCGAGCCCTACCAGGGCATCTGTGGGC CCTGACCTCTGCCTTCTTGGTGGTGTCCCTGTGAT C 66 Fgf3 ENSMUSG GAAGATTGGCTCGTGACCCTGACTCTCAAGGATGA CACTGAGCTGGCTTGCCAGATGTGATC 70 Fgf3 ENSMUSG GGTACTTTTTCAGCCAGCCTAGGNACCATGAATGG NAATGGTGTGTCTTCATACACAGTACAGGTAGGTTC TAAGTC 80 Fgf3 ENSMUSG GTGCTNCCACCATCNGNAGGAGAGACTTCTGTCAC CTTGNAATAGTCAGAGCTCTGTATGAGAGTCCCTG GGCTATCAAGTGTGTTTTATGGGAGTCACAGTACCT CATACTGAGCACTGGAGTCTTAGTCCTCTGAGGTC 85 Fgf3 ENSMUSG AGCGCGCAGGGGTGTTGGGGGGATNNCATCGACC NGAAAATTCTCTTTTTACTCTAATGCCCACCGTACC CCATTGTCTTTGCAACAAAAATAACTCGTGTTCCCC ATGCAATGACTTTCTTNCCATCGATGTCGACACCAG TCTCATTCAGCCACGGTCTCTCCTAGCAACGGTTAC TCTA 86 Fgf3 ENSMUSG CCCTCAGAGGCNCCNANTCTCTANANGCNTGCTGC GTNNNCTGAGACCCCTTTGNCGTGAGGGGGATCTA AATGTACCCTTTTACTGATC 87 Fgf3 ENSMUSG GCGTGGGGCAGAGACCCTGTTNCNNCCTGGCNAG AAACAGAGGCCCTGGGAGATCCTTGAGGGTGCTCA GCTGTGGAGAGACATGTGCATTCAGCATGCTGAAG AGGGCCTGCTACCCTAAATGAGGTTCTCAGGGTGG AAAATGTCCCAGTGTGTGCTAGTAATAGCTTCTGTA TCGTGGAGGTCCCCCCACCCCAACACTTCTCAGGA TCCCATCGATGTCGACACCAGTCTCATTCAGCCAC GGTCTCTCCTAGCAACGGTTACTCTA 91 Fgf3 ENSMUSG ATCTTGAACTTCGAGTCTTCCAGAGTCTCTGACTCA AGCCCCTTAGCAGCTGGAACTTGCTCTTTGAAAGC TGTAAAAGGCATGCAA 96 Fgf3 ENSMUSG ACACCCGTGTGTGGGTCACTTGTGAAGCTCTGTCT GTGGACAAAAGTSTCTGTCTCAGAGATGGACCCAG GATC 98 Fgf3 ENSMUSG GGTGGGCCTGNGGGGGTGACATCCGCCAATTTGN AAAGGTCAGGGAGGCCACTCCTCCTCCCAGGATGA GATCCCATCGATGTCGACACCAGTCTCATTCAGCC ACGGTCTCTCCTAGCAACGGTTACTCTA

19 103 Fgf3 ENSMUSG GGGTGGGACCTTTTNTGATACCTCAGGAAGTCCTT NTTCTTTGAGGCCCTTGGCAGATAAGGAACTGAGG TCAAGAGCTCAGGGTCCAGGGAGCTATTCCCTGAA CCTGGNCTCTCCCCTNTCAGCCTNCCANGTGGTGT CATNCNGTGCNCACATTGTGGGATC 104 Fgf3 ENSMUSG AGGCCTANGTTGTACATAACAATCTTNNGGCTGCG CTAGAGAANCNTAGCACGCTCTCCTGCTATTCCAG GTCANCTATNATCAGNAACCTGAGCACTGTGCTGT GCCTTTGTTGATAAGCTCCTTGGCAGCAATTAACAG CACTGAGCCATAAGTGAGGCAGGGCAGCCTTCACA CATGCTCTTGACTGAGAATAGGCAAGCCTGCAGGA GCTGCACAGCAAATACCCAGCCTGCATCTCCCCTT CACTCTGCATCAGCCTTGGGCCAGGCTGGATC 106 Fgf3 ENSMUSG TGCTGCAGGCGCGGCATTTACAGCTGGGTACATGC CTTTAATCACAGCACTCAGGAGGCAGGGTCAGGCA GATC 133 Fgf3 ENSMUSG TAANTNTNNGGCNCGGCGCGGCNTGTACTTTCTGT CCCCTTGAGGGCAAGGGTTATGTTCTCCTTCCCCA GAACCATGATCCCATCGATGTCGACACCAGTCTCA TTCAGCCACGGTCTCTCCTAGCAACGGTTACTCNA AANNCNNGGGGGNTGANGNGANAANAANATTTTNT GCTGNAGGNNCGGCANTGANNTATCTGTCCCCNTA AGANAAGGATNATNTTCTCCTTCCCCAAAGNCGTG ATCCGAGCGNNTTCCANCCATANGATTANACCTGT GTCTCTCNGTTCTNTAAA 111 PT Fgf3 ENSMUSG TCCTCTGTGCCTCTGCNATCTNNNCCTTTCTCTGAA TTCCTGCTTTGAGTTCCTGCCNTGANCTNCCTAAGT GTGACTTGTGACCTGGGTAGTTATCTCTGATCTTGG TGTTCATCACAGCAACAGAAGAACACTGGAGCAAC TTACTGTGTGGTCTTGTGTTGGCATCTCTGATCCTT CTCTGGAANATGTGATAACNACCCTGACTTGTTTCC CC 128 PT Fgf3 ENSMUSG TTGGGGTNCAGGTAGNAAAGCCACCAGGAACACAC AGTGTTAAACTGTGGTGAGGGCTAGATTCAAAGCT CCTAAAGCCATCCTTGAAACCCCTCTCCATCCAGTG CTTTTANGATGATGAATCACTGGAGNCCCCTGTCCT CAGNTTCCATCTCTGCCTGCCGCTGTCCACGTGGN CCCGGTG 135 PT Fgf3 ENSMUSG GCTCCAGCTTCAGCATGGANCCTCTCGAATTTCACT CAAGCGATAGCGTCTCTCAACAGAGGTGGACATCT GTATGCAAGAGTTTCNGCACCTGTGGTCCTGGCGT GA 140 PT Fgf3 ENSMUSG CTTGAGGGTCACCAGGAGAACACACAGGATGATAA GGGCAAAGCCCCAGGTTCACACAAAAACTCTTCAT CTGCCCACTGAGTTCATGAGCATTAGGGTATGCTT AAATAGGGATTCATATCTGGGTGTGGCAGCTCACT CCTTTAATCCCAGTACTTGGGAGGCNGAGGCNGGT GATC 144 PT Fgf3 ENSMUSG CCTGGGTGTCTCCCTAGGCCAGAAGATAGTGTCTG ATC 161 PT Fgf3 ENSMUSG GGAAGTATTTATGAGGGGGCNGGGTGNAAGGGTA TTTGGGGGTCTGGCCCTGGGAAGCTGGAGCCAGC ATGATC 173 PT Fgf3 ENSMUSG GCCAGGATGTCNTTCCCACNGCGTGCNCCAGNTGC TTGCGCGCCTACTCTAGTTTTAGGGGAGAAGCAGG NTAGAAAGGGGTCTTGTGATC 174,2 PT Fgf3 ENSMUSG AAACACAGAGCTAGGCCTGGNGGCAGGAATAAATG GCCCACGGATTGATC 177 PT Fgf3 ENSMUSG GGTATAGCTAAGGCATGAAGAGATTAGTGTCACCA ACTAGGTGACAAGTGGCAGAGGCAGCCCCCTGGC CAGCATCTGGTTGGTAGTCAGAGATAAGAGGGTAC GTGATGC

20 191 PT Fgf3 ENSMUSG GGCAGGAAGGAGCTGAGTTCAGGCAGNAAGTCCT CGCCAGCTGCTGATGATTATGGTGAACTTGGTCTG GGCCGTGCCAGAGTCACTGTGAACACCGAGGAAA AANAACCAAGNGCCTGAAANAGCNGNCNNATCTNC ATATNNTACNCCATTC 96 PT Fgf3 ENSMUSG AGACAACTGGATGNAGGAGGNATTTTTCGCCGGCC TAGACTATGNCAGGCATNTGGTGAGAACTTGCATA CANAGTCACNTGNAGGTTCTAAGTCCCATCCACAC CCACATGAGGTNGAGTGTAACTCTCCCNAAGTTCA ACGGNTACNTCCTG 72 Fgf3 ENSMUSG CAGGTCCACATGGNAATCTCACTGNCTGGAATGCT CTGAAATGTCTATGTGCCTCCCCATGGGGCTTGTG TGCGTGTGTGTGTCCCAGCCTACAGCCAAATTTCTT CATCAGGACACTAATGGCTGATC 14 Fgf4 ENSMUSG GGGTCTCCTGGTAATCAGTGATCTACCTGCCTCTG CATTCCTAATGCCGGGATTAAAGGAGTGCACCACA GGGCCTGGTGATC 82 Fgf4 ENSMUSG GTTGGGCNATGCCTGCTAACCTTAGCTCCTAGGNA AATGGNGNCANGTAGGCATCAGAAATTCAAGGTCA TCTTTAGATGACATACGTCACAGTTCAGGTACAGAC CTGTGGCTATGAGACCGTCTTTTAGGAAAATAACAA GAAGAAAAGACATTTCAACTGTCTTCTCCCCAACAC TCTTGGAGCCTAGGGCCTGGATTTCCATCGATGTC GACACCAGTCTCATTCAGCCACGGNCTCTCCTAGC AACGGTAACTCNA 71 Fgf6 ENSMUSG CCTAAGGGTTTTTTTTGCCCCAGATCCTACATAAAA AAGCTGGGTGTGGTGACATGTGCTTGTAATGCCCA GGATC 76 Fgf6 ENSMUSG TGTNTTGTGCAAGGCTGCGCCAGTGCCTGGCAAAC ACAGAAGTAGATGCTCANAGTCATCTATTGGATGG AACANAGGGCCCCCCAATGGAGGAGCTCGAGAAA GNACCCAAGGAGCTGAGTGAGGTG 95 Fgf6 ENSMUSG TCATCACTNTGTCCCGGGGAGCAGGACGTGTTCAG GGCACGCTGCAGGCTCTCGTCTTCTTAGGCGTCCT AGTGGGCATG 4 Fgf8 ENSMUSG CAGTGGGACTGTAAAAGTGCTATTGCCTGCCAAAT CACTGACAGGATAAAAGCTACCATCGGTTGGCAGG TGAAGCCACCAAAGGTGGAAGATAGTCTAATGGCT CAGTCAGGTGGCCCCCATCCATCCATCCAACACTA CCTGCAGAGCTACAGCTCTGCCCTGAGCTTTGATC 58 Fgf8 ENSMUSG TCCNATCCTCCTCCTTCAGAAAGGCAGGGGACAGA ACACCACCGTCTCCATGCCGGTGTGATGATGACTC GTGTGAAAAGCCGAAAGGGAGCCTGGGAAGAGAG AAGAGCAGGGGCACAGGTGCCCCGGACAGAAGAG GAGGGCAGGTTTCCTGAGTGGTAGCCTGATC 94 Fgf8 ENSMUSG GNTCTGNNNCATNGCATATTCTGGGCTACCACATG CATGGNAGGCCTGTGGTNGGCCAAAGCNAGTCTG ATC 97 Fgf8 ENSMUSG CATTCAGNAANCAGAAACATTAGNTNNCTGCTCCC GAAAANNTCAAGCAGCGACAGTACNCNGGCCCTTT TNAGCTCTTGAGCTCATTTGGCTCATTTTTGTCTCC TGGCTCTTANNCCCTCAACTAACAAACCGCACCTCA CTTATGGGTGACCTTGAAGCCACTCTCCCTCCTAG AGCTGCTACATCGCATCCCGTCACAGGANATCTGC TGGCAGCTCAGGATCCCATCGANGTNNACACCNGG CNCATTCACCCCCGGTCTCTCCNNGCAANGGNNNC TCTA